Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin - Concepedia

Concepedia

Publication | Closed Access

Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin

142

Citations

23

References

2019

Year

Dae-Won Lee, Sae‐Won Han, Jeong Mo Bae, Hoon Jang, Hyojun Han, Hyoki Kim, Duhee Bang, Seung‐Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang,

Clinical Cancer Research

Abstract

TMB-high is associated with better prognosis in patients with colorectal cancer treated with curative surgery followed by adjuvant fluoropyrimidine and oxaliplatin chemotherapy.

References

	Year	Citations

Page 1